Evidence map›Paper›PMID 41331973›Full record

ArticleMagnetic resonance in medicine2026

First In Vivo

Simon Schmidt, Arcan M Ertürk, Gregory J Metzger

Abstract read
In one paragraph

Article in Magnetic resonance in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. First In VivoMagnetic resonance in medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Simon SchmidtCenter for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0003-1835-4002
Arcan M ErtürkCenter for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA.
Gregory J MetzgerCenter for Magnetic Resonance Research, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0002-3187-6529

Funding

TRD4 - Ultrahigh Field Engineering and SafetyP41EB027061 · NIBIB · UNIVERSITY OF MINNESOTA · PI Gregory John Metzger, KAMIL UGURBIL · 2019 to 2026
$11.7M
Development of Enabling Technologies for Clinical Ultrahigh Field Body MRIR01EB029985 · NIBIB · UNIVERSITY OF MINNESOTA · PI METZGER, GREGORY JOHN · 2021 to 2024
$2.4M
NIBIB NIH HHS P41 EB027061NIBIB NIH HHS R01 EB029985
6 · The paper itself

Abstract

purposeTo demonstrate the first in vivo human

methodsA custom-built eight-channel

resultsThe array's electromagnetic model showed good agreement with experimental data, with B

conclusionsWe successfully performed the first in vivo human

Indexed as

Magnetic Resonance ImagingSodiumAdultEquipment DesignHumansImage Processing, Computer-AssistedKidneyMalePhantoms, ImagingProtonsSodium IsotopesProtonsSodiumSodium Isotopes10.5 Tbody MRIself‐gatingsodium MRIultra‐high field MRI

Identifiers

PMID41331973
PMCPMC12850562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.